Prognostic effect of pre- and post-admission antibiotic treatment in paediatric acute mastoiditis

E Carmel1, J H Curotta1, A T Cheng1

  • 1Department of Paediatric Otolaryngology,Children's Hospital at Westmead,Sydney,Australia.

Insights

Pre-admission antibiotic treatment for pediatric acute mastoiditis increases complication risk. Post-admission antibiotic therapy for 10 days is recommended for uncomplicated cases to prevent sequelae.

Area of Science:

  • Otolaryngology
  • Pediatric Infectious Diseases
  • Pharmacology

Background:

  • Acute mastoiditis is a serious middle ear infection in children.
  • Antibiotic therapy is the cornerstone of treatment, but its timing and duration can influence outcomes.
  • Understanding the impact of pre- and post-admission antibiotic use is crucial for optimizing patient care.

Purpose of the Study:

  • To evaluate the impact of antibiotic treatment administered before and after hospital admission on the short- and long-term outcomes of pediatric acute mastoiditis.
  • To identify risk factors for complications in children with acute mastoiditis.

Main Methods:

  • Retrospective study design.
  • Analysis of data from 88 children diagnosed with acute mastoiditis between 2003 and 2012.
  • Investigation of the relationship between antibiotic therapy timing and the development of short- and long-term sequelae.

Main Results:

  • The median duration of post-discharge antibiotic therapy was 10 days.
  • No sequelae were observed within two weeks of completing antibiotic therapy.
  • 14 out of 40 patients experienced significant long-term sequelae, including recurrent otorrhoea, acute otitis media, and need for ventilation tube insertion.
  • Complication rates were significantly higher in patients who received pre-admission antibiotics (52%) compared to those who did not (27%).

Conclusions:

  • Pediatric patients with acute mastoiditis treated with antibiotics prior to hospital admission face an elevated risk of developing complications.
  • A 10-day course of oral antibiotic therapy following hospital discharge is recommended for uncomplicated acute mastoiditis.
  • Early antibiotic administration may be associated with increased long-term complications.
Abstract

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
581
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
511
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
5.2K
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
70
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
999